vimarsana.com


Anteris Technologies has 3D single-piece Transcatheter Heart Valve DurAVR™ featured during TVT 2021
CEO Wayne Paterson said: “Having DurAVR™ recognized at this very important meeting is a clear demonstration of support for our potential within the Structural Heart Faculty.”
DurAVR™ was also recognised by founder and chairman emeritus of the Cardiovascular Research Foundation.
Anteris Technologies Ltd (ASX:AVR, OTCQB:AMEUF, FRA:DDF) has had its unique 3D single-piece Transcatheter Heart Valve DurAVR™ featured in the innovation section of the Transcatheter Valve Therapies Structural Heart Summit (TVT 2021).
DurAVR™ was also recognised by the founder and chairman emeritus of the Cardiovascular Research Foundation (CRF), which sponsors TVT 2021.

Related Keywords

Wayne Paterson ,Minneapolis Heart Institute ,Columbia University Professor Of Cardiology ,Cardiovascular Research Foundation ,Transcatheter Heart Valve ,Left Atrial Appendage ,Structural Heart Faculty ,Heart Summit ,Medical Advisory Board ,Abbott Northwestern Hospital ,Paul Sorajja ,Aortic Valve Replacement ,Columbia University ,Interventional Vascular Therapy ,Aortic Stenosis ,வேன் பேட்டர்சன் ,மினியாபோலிஸ் இதயம் நிறுவனம் ,இருதய ஆராய்ச்சி அடித்தளம் ,இதயம் உச்சிமாநாடு ,அப்போட் வடமேற்கு மருத்துவமனை ,பெருநாடி அடைப்பான் மாற்று ,கொலம்பியா பல்கலைக்கழகம் ,தலையீடு வாஸ்குலர் சிகிச்சை ,பெருநாடி ஸ்டெனோசிஸ் ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.